Philips: awarded EU grant for personalized cancer treatment.
(CercleFinance.com) - Philips is in the news today, wtih the Dutch giant now refocusing on medical apparatus, lighting and domestic appliances.
Beyond the acquisition of the US start-up company Analytical Informatics, Philips' consortium has been awarded a 6.3 million euros research grant to develop an integrated approach for personalized cancer treatment.
The four-year research project aims to increase the accuracy of genetic and functional characterisation of primary breast cancer and rectal cancer by combining two diagnostic technologies: advanced blood tests called liquid biopsy and magnetic resonance imaging.
The award is part of "Horizon 2020," a huge EU research and innovation program, which aims to ensure that Europe produces "world-class science."
Copyright (c) 2017 CercleFinance.com. All rights reserved.
Beyond the acquisition of the US start-up company Analytical Informatics, Philips' consortium has been awarded a 6.3 million euros research grant to develop an integrated approach for personalized cancer treatment.
The four-year research project aims to increase the accuracy of genetic and functional characterisation of primary breast cancer and rectal cancer by combining two diagnostic technologies: advanced blood tests called liquid biopsy and magnetic resonance imaging.
The award is part of "Horizon 2020," a huge EU research and innovation program, which aims to ensure that Europe produces "world-class science."
Copyright (c) 2017 CercleFinance.com. All rights reserved.